Table of contents

Research Article

• Neonatal screening for cystic fibrosis. (1 July, 1995)

  P D Phelan
• Pulmonary arteriovenous malformations. (1 July, 1995)

  R J Robertson, I R Robertson
• Molecular diagnosis of tuberculosis: the need for new diagnostic tools. (1 July, 1995)

  P Godfrey-Faussett
• Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. (1 July, 1995)

  J E Dankert-Roelse, G J te Meerman
• Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients. (1 July, 1995)

  T J Haitjema, T T Overtoom, C J Westermann, J W Lammers
• Validation of an asthma quality of life diary in a clinical trial. (1 July, 1995)

  M E Hyland, G R Crocker
• Randomised trial of an asthma self-management programme for adults. (1 July, 1995)

  R M Allen, M P Jones, B Oldenburg
• Microbial inciters of acute asthma in urban Nigerian children. (1 July, 1995)

  D A Gbadero, A W Johnson, W I Aderele, O D Olaleye
• Factors affecting total and "respirable" dose delivered by a salbutamol metered dose inhaler. (1 July, 1995)

  M L Everard, S G Devadason, Q A Summers, P N Le Souëf
• Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. (1 July, 1995)

  C S Ulrik
• Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: correlates for success. (1 July, 1995)

  N Ambrosino, K Foglio, F Rubini, E Clini, S Nava, M Vitacca
• Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. (1 July, 1995)

  A P Sachs, G H Koëter, K H Groenier, D van der Waaij, J Schiphuis, B Meyboom-de Jong
• Effect of ambient levels of smoke and sulphur dioxide on the health of a national sample of 23 year old subjects in 1981. (1 July, 1995)

  J F Scarlett, J M Griffiths, D P Strachan, H R Anderson
• Exposure to cobalt chromium dust and lung disorders in dental technicians. (1 July, 1995)

  A I Seldén, B Persson, S I Bornberger-Dankvardt, L E Winström, L S Bodin
• Ethnic origin and lung function of infants born prematurely. (1 July, 1995)

  B Yüksel, A Greenough
• Changes to alveolar macrophage phenotype in HIV infected individuals with normal CD4 counts and no respiratory disease. (1 July, 1995)

  M C Lipman, M A Johnson, D H Bray, L H Poulter
• Combined pulmonary and thoracic wall resection for stage III lung cancer. (1 July, 1995)

  S S Shah, P Goldstraw
• Effects of topical budesonide on epithelial restitution in vivo in guinea pig trachea. (1 July, 1995)

  J S Erjefält, I Erjefält, F Sundler, C G Persson
• Phrenic neuropathy in chronic renal failure. (1 July, 1995)

  U Zifko, M Auinger, G Albrecht, T Kästenbauer, H Lahrmann, W Grisold, T Wanke
• Different perceptions of disease severity and self care between patients with cystic fibrosis, their close companions, and physician. (1 July, 1995)

  J Abbott, M Dodd, A K Webb
• Sleep-related breathing disorder.2. Pathophysiology of obstructive sleep apnoea. (1 July, 1995)

  D P White
• Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis. (1 July, 1995)

  C P Maguire, J P Hayes, M Hayes, J Masterson, M X FitzGerald
• Pseudomembranous necrotising bronchial aspergillosis complicating chronic airways limitation. (1 July, 1995)

  A G Nicholson, K M Sim, B F Keogh, B Corrin
• Treatment of pulmonary aspergilloma in cystic fibrosis by percutaneous instillation of amphotericin B via indwelling catheter. (1 July, 1995)

  P J Ryan, D E Stableforth, J Reynolds, K M Muhdi
• Colonisation with Aspergillus of an intralobar pulmonary sequestration. (1 July, 1995)

  J Freixinet, J de Cos, F Rodriguez de Castro, G Julia, T Romero
• Commentary: unusual manifestations of aspergillosis. (1 July, 1995)

  D W Denning
• Emergency treatment of asthma. (1 July, 1995)

  P W Barry, C O'Callaghan
• Toxicity of isoniazid and rifampicin combination. (1 July, 1995)

  I A Campbell